Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Conditions

• Adult Nasal Type Extranodal NK/T-cell Lymphoma
• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Hepatosplenic T-cell Lymphoma
• Peripheral T-cell Lymphoma
• Post-transplant Lymphoproliferative Disorder
• Prolymphocytic Leukemia
• Recurrent Adult T-cell Leukemia/Lymphoma
• Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
• Recurrent Mycosis Fungoides/Sezary Syndrome
• Small Intestine Lymphoma
• T-cell Large Granular Lymphocyte Leukemia

Interventions

• DRUG: azacitidine
• DRUG: bortezomib
• PROCEDURE: Correlative studies

Sponsor

Pierluigi Porcu

Collaborators

• [object Object]
• [object Object]